1. Home
  2. NVCT

NVCT

Nuvectis Pharma Inc.

Logo Nuvectis Pharma Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-24-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Founded: 2020 Country:
United States
United States
Employees: N/A City: FORT LEE
Market Cap: 121.2M IPO Year: 2022
Target Price: $21.00 AVG Volume (30 days): 93.4K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.43 EPS Growth: N/A
52 Week Low/High: $6.20 - $18.65 Next Earning Date: 05-08-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks:

Stock Insider Trading Activity of Nuvectis Pharma Inc. (NVCT)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
BENTSUR RON NVCT Chairman & CEO Mar 18 '24 Buy $10.29 5,000 $51,450.00 3,242,484 SEC Form 4